NCT03431168View on ClinicalTrials.gov

A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2022

Conditions
HIVPregnancy MalariaSexually Transmitted Infection
Interventions
DRUG

Azithromycin/TMPS

2 tabs po daily x 3 days at enrollment and at each monthly follow up visit

DRUG

Placebo/TMPS

2 tabs po daily x 3 days at enrollment and at each monthly follow up visit

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03431168 - A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV | Biotech Hunter | Biotech Hunter